Clinical Trial

Revive Toric RWE Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 28, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a post-market observational clinical investigation. The objective of this observational study is to evaluate the visual performance and HCP satisfaction of REVIVE samfilcon B custom toric contact lenses.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-01-16; most recent amendment 2025-11-26.
Trial Details
NCT Number NCT06785194
Lead Sponsor Bausch & Lomb Incorporated
Conditions Astigmatism
Enrollment 30 participants
Start Date 2026-05
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-11-28